Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,071 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glycemia reduction in type 2 diabetes-Hypoglycemia outcomes: A randomized clinical trial.
Seaquist ER, Phillips LS, Ghosh A, Baker C, Bergenstal RM, Crandall JP, Goland RS, Gramzinski MR, Hox SH, Hsia DS, Johnson ML, Lachin JM, Raskin P, Valencia WM, Waltje AH, Younes N; GRADE Research Group. Seaquist ER, et al. Among authors: johnson ml. PLoS One. 2024 Nov 15;19(11):e0309907. doi: 10.1371/journal.pone.0309907. eCollection 2024. PLoS One. 2024. PMID: 39546502 Free PMC article. Clinical Trial.
Plain language summary: tarlatamab for patients with previously treated small cell lung cancer.
Ahn MJ, Cho BC, Felip E, Korantzis I, Ohashi K, Majem M, Juan-Vidal O, Handzhiev S, Izumi H, Lee JS, Dziadziuszko R, Wolf J, Blackhall F, Reck M, Alvarez JB, Hummel HD, Dingemans AC, Sands J, Akamatsu H, Owonikoko TK, Ramalingam SS, Borghaei H, Johnson ML, Huang S, Mukherjee S, Minocha M, Jiang T, Martinez P, Anderson ES, Paz-Ares L. Ahn MJ, et al. Among authors: johnson ml. Future Oncol. 2024 Nov 12:1-10. doi: 10.1080/14796694.2024.2402152. Online ahead of print. Future Oncol. 2024. PMID: 39530627
Older Adults Benefit From Virtual Support for Continuous Glucose Monitor Use But Require Longer Visits.
Weinstock RS, Raghinaru D, Gal RL, Bergenstal RM, Bradshaw A, Cushman T, Kollman C, Kruger D, Johnson ML, McArthur T, Olson BA, Oser SM, Oser TK, Beck RW, Hood K, Aleppo G. Weinstock RS, et al. Among authors: johnson ml. J Diabetes Sci Technol. 2024 Nov 2:19322968241294250. doi: 10.1177/19322968241294250. Online ahead of print. J Diabetes Sci Technol. 2024. PMID: 39487727 Free PMC article.
Stem cell activity-coupled suppression of endogenous retrovirus governs adult tissue regeneration.
Lyu Y, Kim SJ, Humphrey ES, Nayak R, Guan Y, Liang Q, Kim KH, Tan Y, Dou J, Sun H, Song X, Nagarajan P, Gerner-Mauro KN, Jin K, Liu V, Hassan RH, Johnson ML, Deliu LP, You Y, Sharma A, Pasolli HA, Lu Y, Zhang J, Mohanty V, Chen K, Yang YJ, Chen T, Ge Y. Lyu Y, et al. Among authors: johnson ml. Cell. 2024 Oct 23:S0092-8674(24)01155-3. doi: 10.1016/j.cell.2024.10.007. Online ahead of print. Cell. 2024. PMID: 39476839
First-In-Human Dose-Escalation Study of Fianlimab, an Anti-Lymphocyte Activation Gene-3 Antibody, with Cemiplimab in patients with advanced malignancies.
Lakhani NJ, Papadopoulos KP, Johnson ML, Park H, Wang D, Yap TA, Dowlati A, Maki RG, Ulahannan S, Lynce F, Kelly K, Williamson S, Malhotra J, Chen S, Gonzalez Ortiz A, Jankovic V, Paccaly A, Masinde S, Mani J, Lowy I, Gullo G, Sims T, Kroog G. Lakhani NJ, et al. Among authors: johnson ml. Clin Cancer Res. 2024 Oct 18. doi: 10.1158/1078-0432.CCR-23-3883. Online ahead of print. Clin Cancer Res. 2024. PMID: 39422598
1,071 results